Natural, Semi-Synthetic, and Synthetic Cannabinoids: Complete Guide 2026

Β 




Expert Guide Β· Herbeevor 2026

Natural, semi-synthetic, and synthetic cannabinoids:
what you need to know

Behind every CBD product lies a molecule whose originβ€”plant-based, transformed, or entirely lab-madeβ€”determines its safety profile, legality, and effectiveness. This guide provides you with the keys to understanding these differences and making informed choices.

Natural β€” CBD, CBG, CBN, CBC Semi-synthetic β€” HHC, Delta-8, THCP Synthetic β€” Spice, JWH, Nabilone

Three families, three realities

Expert Guide

The CBD market has become considerably more complex since 2021. Alongside well-documented natural molecules like CBD and CBG, new substances resulting from chemical transformations have appearedβ€”often presented as legal alternatives, but rarely with the necessary transparency regarding their safety or regulatory status. Knowing how to distinguish these three families is now essential for any informed consumer.

β—Ž

Herbeevor's Commitment: we only sell natural cannabinoids from certified European hemp. Each batch is analyzed by an independent laboratory (COA), with a THC content of less than 0.3% in the final product. Our traceability policy β†’

Natural cannabinoids

Derived from the plant

Natural cannabinoidsβ€”or phytocannabinoidsβ€”are extracted directly from hemp (Cannabis sativa L.) without modifying their molecular structure. They constitute the only family of cannabinoids with a well-documented safety profile, established legality in Europe, and possible traceability from plant to finished product.

Phytocannabinoids

Directly derived from hemp, without chemical transformation

Cannabis sativa contains over 100 distinct cannabinoids. The four main molecules available at Herbeevorβ€”CBD, CBG, CBN, CBCβ€”act synergistically with the plant's natural terpenes and flavonoids to produce what researchers call the entourage effect.

Why choose them
Documented safety profile β€” decades of clinical studies on CBD and CBG, no serious toxicity signals at usual doses.
Established legality in Europe β€” compliant with EU regulations as long as THC is below 0.3% in the finished product.
Entourage effect β€” the synergy between cannabinoids, terpenes, and flavonoids amplifies the effects of each isolated molecule.
Complete traceability β€” from seed to capsule, every production step is documented and verifiable.
COA analysis compliance β€” each batch is subjected to independent laboratory testing before being put on sale.
Acidic forms β€” CBDA and CBGA

Before decarboxylation (the application of heat), CBD and CBG exist in the fresh plant in their acidic formsβ€”CBDA and CBGA, respectively. These precursors are the subject of promising research into their interaction with certain receptors, but remain less clinically studied than their active forms. They are present in varying concentrations in unheated Full Spectrum extracts.

The endocannabinoid system β€” why these molecules work

Mechanism of action

All cannabinoid moleculesβ€”whether natural, semi-synthetic, or syntheticβ€”interact with the endocannabinoid system (ECS), a network of receptors present throughout the human body. This system naturally regulates sleep, pain, mood, appetite, and immune response. Understanding its function helps grasp why the action profile varies so greatly from one family to another.

CB1 receptors β€” central nervous system

Concentrated in the brain and spinal cord, CB1 receptors are responsible for psychoactive effects when strongly activated. THC, semi-synthetic cannabinoids like HHC, and synthetics act as direct CB1 agonistsβ€”with highly variable intensities depending on the molecule. CBD, on the other hand, acts in a modulatory and indirect manner, without directly activating these receptors, which explains the absence of psychoactive effects.

CB2 receptors β€” immune system and peripheral tissues

Primarily present in the immune system, peripheral tissues, and skin, CB2 receptors are associated with anti-inflammatory effects and recovery mechanisms. CBD, CBG, and CBC preferentially interact with this pathway, which contributes to their favorable safety profile. Topical CBD cosmetics act notably via this cutaneous pathway, without entering systemic circulation.

CBD is not a direct agonist of CB1 or CB2 receptors. It primarily acts via allosteric mechanisms, interactions with TRPV1, 5-HT1A receptors, and other signaling pathways. It is this indirect mode of action that fundamentally distinguishes CBD from psychoactive substancesβ€”natural or synthetic. Source: Blessing et al., Neurotherapeutics (2015); Russo, British Journal of Pharmacology (2011). Herbeevor Cannabinoid Guide β†’

Semi-synthetic cannabinoids

Caution required

Semi-synthetic cannabinoids are produced in the laboratory from a natural cannabinoidβ€”usually CBDβ€”which undergoes one or more chemical transformations to modify its molecular structure and create a new substance with different effects. This process is legal in some cases, but the regulatory status of these molecules is rapidly evolving in France and Europe.

Between nature and chemistry

Obtained by chemical transformation of a natural cannabinoid

Their common point: a starting plant molecule (CBD or THC) modified by hydrogenation, isomerization, or alkyl chain elongation. The resulting effects can differ radically from the original molecule.

Key points of vigilance
Unstable legal status β€” France has classified several of these molecules as narcotics since 2023, and other European regulations are being harmonized.
Limited safety data β€” few or no published clinical trials on long-term effects. Available studies are mainly preclinical.
Risk of chemical residues β€” if the transformation process is poorly controlled, solvents or reagents can contaminate the final product.
Possible psychoactive effects β€” some molecules (Delta-8 THC, THCP) significantly activate CB1 receptors, with effects similar to THC.
Absence of entourage effect β€” isolated molecules, without the synergy of natural hemp terpenes and cannabinoids.
Most common molecules
HHC
Hexahydrocannabinol Obtained by hydrogenation of THC or CBD. Moderate to intense psychoactive effects depending on the dose. Prohibited in France since the decree of June 13, 2023. Illegal in France
Delta-8
Delta-8 THC Isomer of Delta-9 THC obtained by isomerization of CBD. Psychoactive effects lighter than Delta-9. Legal status varies by European country. Uncertain status in EU
THCP
Tetrahydrocannabiphorol THC analog with an extended alkyl chain. Very high affinity for CB1 receptorsβ€”powerful and unpredictable effects. Very few studies available. Not authorized in France
Delta-10
Delta-10 THC Another THC isomer produced in the laboratory. Almost no clinical data. Frequent presence of contaminants reported in independent analyses. Insufficient data
⚠

Legal point France 2026: HHC, HHCP and their derivatives have been classified as narcotics by ministerial decree since June 2023. Their sale, possession and use are liable to criminal prosecution in France, regardless of the country of manufacture of the product. Consult the CBD legality guide 2026 β†’

Synthetic cannabinoids

Proven danger

Synthetic cannabinoids are entirely manufactured by chemical synthesis, without any plant raw material. They mimic the action of natural cannabinoids on endocannabinoid receptors, but with an affinity often 10 to 100 times higher for CB1 receptorsβ€”making their effects unpredictable, potentially serious, and very far from the classic CBD experience.

No plant origin

Entirely lab-made β€” no plant raw material

Their only common point with natural CBD is their ability to interact with cannabinoid receptors. For the restβ€”safety, legality, predictability of effectsβ€”they constitute a radically distinct category that every CBD consumer must be aware of to avoid confusion.

Why avoid them absolutely (outside supervised medical use)
No safety data for non-medical use. No clinical trials, no established tolerance profile.
Extreme CB1 affinity β€” some molecules (JWH-018, AM-2201) are up to 100 times more potent than natural THC on CB1 receptors.
Illegal throughout the EU for any non-medical use, classified as narcotics or narcotic analogues.
Documented cardiovascular, neurological, and psychiatric risks: epileptic seizures, arrhythmias, psychotic episodes, hospitalizations.
No traceability β€” actual composition often unknown even to sellers, massive variations in concentration from one batch to another.
Examples to know
Spice / K2
Mixtures of synthetic cannabinoids Sprayed on neutral plants. Extremely dangerous, responsible for hundreds of hospitalizations in Europe each year. Totally illegal throughout the EU.
JWH-018
Research synthetic cannabinoid Potent CB1 receptor agonist. Unpredictable effects and potentially lethal at high doses. Classified as a narcotic throughout the EU.
Nabilone
Medical cannabinoid (strictly controlled use) Medical exception prescribed for chemotherapy-related nausea. Exclusively hospital use under medical prescriptionβ€”not an alternative to CBD.
⊘

Warning: synthetic cannabinoids are sometimes presented online as legal substitutes for cannabis or CBD. This is neither legally nor scientifically accurate. Their acquisition, possession, and use expose individuals to serious criminal risks and documented health hazards. They have no connection with the world of legal CBD.

Comparative table β€” the three families

Summary

A direct comparison of the essential criteria for evaluating each cannabinoid family: legality, safety, entourage effect, and traceability.

Criterion Natural (CBD, CBG, CBN, CBC) Semi-synthetic (HHC, Delta-8…) Synthetic (Spice, JWH…)
Origin Hemp plant (Cannabis sativa) Chemically transformed CBD or THC Total chemical synthesis, no plant
EU Legality (2026) Legal (THC < 0.3%) Variable β€” often prohibited Illegal outside medical use
Legality in France Compliant HHC prohibited since 2023 Narcotics
Safety data Well documented Limited Insufficient / dangerous
Entourage effect Yes (Full Spectrum) No No
Traceability Plant β†’ product (COA) Partial None
Psychoactivity No (CBD, CBG, CBN, CBC) Possible to probable Yes, often intense
Available at Herbeevor Yes β€” complete range No No

Which natural molecule to choose according to your objective?

Herbeevor Recommendations

Remaining within the framework of natural cannabinoidsβ€”the only ones that are legal, safe, and traceableβ€”each comfort objective corresponds to one or two priority molecules. Here are the associations we recommend at Herbeevor.

⚠

Drivers: Full Spectrum products containing up to 0.3% legal THC can trigger a positive saliva test. It is imperative to choose a Broad Spectrum format certified with 0% detectable THCβ€”capsules, Broad Spectrum oil, or CBD e-liquids. CBD legality and driving guide β†’

Legal framework in France β€” what's changing in 2026

2026 Update

French regulations regarding cannabinoids have seen several significant developments since 2021. Here are the essential points to know for purchasing and consuming legally.

What is legal, what is forbidden

Natural CBD (Full Spectrum, THC < 0.3%): legal for sale, possession, and consumption in France. Hemp flowers and leaves are also authorized since the lifting of the prohibition decree, provided a compliant THC level. Flower legality details β†’
Broad Spectrum CBD (0% detectable THC): legal and recommended for individuals with constraintsβ€”drivers, athletes subject to anti-doping controls, professionals in regulated environments.
HHC, HHCP, and derivatives: classified as narcotics by order of June 13, 2023. Sale, possession, and use are illegal in France, regardless of the concentration or country of origin of the product.
Synthetic cannabinoids (Spice, JWH, etc.): classified as narcotics throughout the European Union. No derogation possible outside strictly supervised medical prescription.
Saliva test and Full Spectrum: a THC level below 0.3% remains legal, but can generate a positive result during a roadside check. The driver's criminal liability may be incurred regardless of the legality of the product consumed. Drivers must choose a certified Broad Spectrum format.

Herbeevor guarantees

Certified Β· Traced Β· 100% natural

Only natural cannabinoids, analyzed batch by batch.

Herbeevor does not market any semi-synthetic or synthetic substances. Our entire range comes from legal Cannabis sativa varieties, cultivated in Europe, with a THC content of less than 0.3% in the finished product, attested by an independent laboratory analysis certificate (COA) available on each product sheet.

β—Ž COA analyses per batch Independent third-party lab report accessible on each product page
βš– THC < 0.3% proven French legal threshold respected β€” documented, not just declared
β—ˆ Complete traceability From seed to finished product β€” documented plant origin and production chain
βœ• Zero medical claims 100% compliant communication β€” comfort, balance, well-being only

All Herbeevor resources



Natural, traceable, certified cannabinoids.

COA analyses available Β· THC < 0.3% proven Β· 100% natural Β· Fast and discreet delivery
No semi-synthetic or synthetic cannabinoids in our range.

Satisfied or refunded Β· Secure payment Β· Expert CBD advice Β· Legal compliance France 2026

Login

Forgot your password?

Don't have an account yet?
Create account